IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.763
EU - Europa 7.959
AS - Asia 6.696
SA - Sud America 3.459
AF - Africa 399
Continente sconosciuto - Info sul continente non disponibili 145
OC - Oceania 4
Totale 32.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.244
BR - Brasile 2.762
VN - Vietnam 2.058
SG - Singapore 1.920
UA - Ucraina 1.667
RU - Federazione Russa 1.590
IT - Italia 896
IE - Irlanda 821
DE - Germania 763
DK - Danimarca 628
HK - Hong Kong 599
SE - Svezia 527
CN - Cina 479
TR - Turchia 453
FI - Finlandia 397
KR - Corea 329
FR - Francia 326
AR - Argentina 274
CA - Canada 188
BD - Bangladesh 154
GB - Regno Unito 153
MA - Marocco 146
IN - India 132
ID - Indonesia 126
EC - Ecuador 121
IQ - Iraq 98
CO - Colombia 92
MX - Messico 90
ZA - Sudafrica 78
PY - Paraguay 57
PK - Pakistan 55
EU - Europa 47
CR - Costa Rica 45
VE - Venezuela 45
AT - Austria 40
CL - Cile 37
PE - Perù 34
TN - Tunisia 34
CI - Costa d'Avorio 33
PH - Filippine 31
GT - Guatemala 29
PR - Porto Rico 28
JP - Giappone 27
CW - ???statistics.table.value.countryCode.CW??? 26
UY - Uruguay 26
UZ - Uzbekistan 26
PL - Polonia 25
EG - Egitto 24
NI - Nicaragua 23
HN - Honduras 22
IL - Israele 22
NL - Olanda 22
DZ - Algeria 21
KE - Kenya 21
SV - El Salvador 21
JM - Giamaica 20
JO - Giordania 20
AE - Emirati Arabi Uniti 19
ES - Italia 19
KZ - Kazakistan 19
TT - Trinidad e Tobago 19
TH - Thailandia 15
AL - Albania 14
SA - Arabia Saudita 13
BE - Belgio 12
BO - Bolivia 11
DO - Repubblica Dominicana 11
MY - Malesia 11
GP - Guadalupe 10
LB - Libano 10
OM - Oman 10
SC - Seychelles 10
BY - Bielorussia 9
NP - Nepal 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
AM - Armenia 7
BG - Bulgaria 7
RS - Serbia 7
SN - Senegal 7
TW - Taiwan 7
EE - Estonia 6
KG - Kirghizistan 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
AU - Australia 4
BH - Bahrain 4
ET - Etiopia 4
GE - Georgia 4
PS - Palestinian Territory 4
RO - Romania 4
SY - Repubblica araba siriana 4
BW - Botswana 3
GN - Guinea 3
KH - Cambogia 3
KW - Kuwait 3
LT - Lituania 3
LV - Lettonia 3
BS - Bahamas 2
CG - Congo 2
Totale 32.317
Salva come PNG Salva come JPEG
Città #
Ashburn 1.764
Jacksonville 1.630
Fairfield 1.006
Singapore 975
Dublin 819
Council Bluffs 717
Ho Chi Minh City 700
Boardman 662
Hong Kong 593
Dallas 498
Wilmington 498
San Jose 439
Hanoi 433
Woodbridge 406
Houston 387
Seattle 358
Princeton 332
San Mateo 330
Lawrence 329
Chandler 307
Cambridge 288
Lauterbourg 285
Centro 277
Moscow 247
São Paulo 237
The Dalles 221
New York 196
Ann Arbor 164
San Diego 138
Des Moines 137
Hefei 127
Los Angeles 119
Milan 119
Da Nang 99
Beijing 94
Rio de Janeiro 86
Haiphong 83
Chicago 63
Curitiba 56
Helsinki 55
Brasília 48
Porto Alegre 48
Belo Horizonte 45
Phoenix 44
Guayaquil 42
Miano 42
Nuremberg 41
Rome 41
Santa Clara 41
San José 39
Biên Hòa 38
Montreal 36
Quito 35
London 34
Thái Bình 34
Toronto 34
Abidjan 33
Munich 33
Saint Petersburg 33
Salvador 33
Baghdad 31
Campinas 30
Orem 30
Ribeirão Preto 30
Brooklyn 28
Hải Dương 28
Atlanta 26
Johannesburg 26
Willemstad 26
São Bernardo do Campo 24
Denver 23
Guarulhos 23
Managua 23
Phủ Lý 23
Shanghai 23
Sorocaba 23
Tashkent 23
Thái Nguyên 23
Can Tho 22
Dhaka 22
Norwalk 22
Asunción 21
Lima 21
Ninh Bình 21
Turku 21
Buenos Aires 20
Buffalo 20
Guangzhou 20
Manaus 20
San Salvador 20
Warsaw 20
Goiânia 19
Guatemala City 19
Naples 19
Palermo 19
Vienna 19
Amman 18
Cape Town 18
Jakarta 18
Nairobi 18
Totale 17.948
Salva come PNG Salva come JPEG
Nome #
Teicoplanin concentrations in cholecystic, pancreatic and hepatic tissues 248
Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. 177
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 177
[Closed surgical treatment in acute severe pancreatitis] 172
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 169
Adequacy of Lymph Node Retrieval for Ampullary Cancer and Its Association with Improved Staging and Survival. 162
Acute necrotizing pancreatitis and fistula treatment: the role of somatostatin - 14 and its analogues. 160
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 153
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. 151
Alchool intake,cigarette smoking and body mass index in patients with alcohol associated pancreatitis 150
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 149
Poorly differentiated resectable pancreatic cancer: Is upfront resection worthwhile? 148
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 146
Intraductal papillary mucinous neoplasms and chronic pancreatitis. 145
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. 145
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 144
Italian consensus guidelines for chronic pancreatitis 139
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 139
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11 138
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 137
Clinical and Patient-Reported Outcomes After Pancreatoduodenectomy for Different Diseases: A Follow-Up Study. 136
Ultrasonography of the pancreas. 7. Intraoperative imaging. 136
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial 136
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 136
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 136
Enhanced recovery pathways in pancreatic surgery: State of the art 134
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 134
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 133
B-Cell Lymphoma Presenting as Acute Pancreatitis. 133
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian association for the study of the pancreas. 131
A preoperative score to predict early death after pancreatic cancer resection 131
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 129
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. 128
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 128
Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study. 128
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. 126
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 124
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. 123
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 122
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 121
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography 121
Alcohol intake, cigarette smoking, and body mass index in patients with alcohol-asociated pancreatitis 121
A systematic review on robotic pancreaticoduodenectomy. 121
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. 120
Neuroendocrine Tumor Disease- An Evolving Landscape. 118
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. 116
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. 116
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 116
Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis 114
Role of Resection of the Primary Pancreatic Neuroendocrine Tumour Only in Patients with Unresectable Metastatic Liver Disease: A Systematic Review. 114
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System. Well-Differentiated Pancreatic Non-Functioning Tumors. 113
Minimally invasive necrosectomy versus conventional surgery in the treatment of infected pancreatic necrosis: a systematic review and a meta-analysis of comparative studies. 113
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 112
Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma. 112
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 112
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 112
Allelotype of pancreatic acinar cell carcinoma. 112
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 111
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. 111
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 110
Cisti splenica epiteliale 110
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 110
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 110
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 110
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 109
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 109
Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma 109
Questions about branch-duct IPMNs with Sendai negative criteria. 109
Anastomotic leakage in pancreatic surgery. 109
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 109
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 108
Pancreatoblastoma in adults: a review of the literature. 108
Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications 108
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 108
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. 108
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. 108
Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial 107
Identification of a novel antibody associated with autoimmune pancreatitis 107
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. 107
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 107
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 107
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 106
Long-term results of Frey's procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients. 106
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. 106
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. 106
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 106
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 106
Treatment trends in metastatic pancreatic cancer patients: Is it time to change? 106
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 105
Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma 105
Pancreas: Insulinoma--new insights into an old disease. 104
Gabesato Mesilato versus aprotinina nella pancreatite acuta necrotizzante. 104
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. 104
Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. 104
Cystic distrophy of the duodenal wall (CDDW): the Verona experience 104
Ofloxacin penetration into bile and pancreatic juice. 103
Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses 103
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 103
In vivo octreotide administration acutely reduces exocrine granule size in the human pancreas 103
Management of functioning endocrine pancreatic tumors. 103
Totale 12.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.281 0 0 0 0 3 179 78 149 116 209 51 496
2022/20231.886 367 189 228 61 56 120 2 32 736 3 49 43
2023/20241.386 328 7 32 349 325 145 18 9 1 8 4 160
2024/20253.651 227 535 39 9 66 21 521 105 1.113 252 299 464
2025/202611.401 498 1.145 1.202 2.765 358 451 1.719 1.136 681 815 115 516
2026/20273.426 862 580 605 1.334 45 0 0 0 0 0 0 0
Totale 32.425